XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Note Receivable [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2018 $ 14,738 $ 51 $ 389,398 $ (16) $ (198) $ (374,497)
Beginning Balance, shares at Dec. 31, 2018   50,652,238        
Net loss (39,961) $ 0 0 0 0 (39,961)
Unrealized (loss) gain on investments 607 0 0 0 607 0
Issuance of common stock under Equity Distribution Agreement, net of issuance costs 73,276 $ 6 73,270 0 0 0
Issuance of common stock under Equity Distribution Agreement, net of issuance costs, shares   6,491,196        
Issuance of common stock under equity incentive and employee stock purchase plans 5,837 $ 1 5,836 0 0 0
Issuance of common stock under equity incentive and employee stock purchase plans, shares   1,217,325        
Repurchased shares upon vesting of restricted stock units for tax withholdings (1,174) $ 0 (1,174) 0 0 0
Repurchased shares upon vesting of restricted stock units for tax withholdings, shares   (107,619)        
Employee stock-based compensation 8,359 $ 0 8,359 0 0 0
Compensation expense related to options granted to consultants 180 0 180 0 0 0
Ending Balance at Sep. 30, 2019 61,862 $ 58 475,869 (16) 409 (414,458)
Ending Balance, shares at Sep. 30, 2019   58,253,140        
Beginning Balance at Jun. 30, 2019 71,460 $ 58 472,661 (16) 353 (401,596)
Beginning Balance, shares at Jun. 30, 2019   58,209,745        
Net loss (12,862) $ 0 0 0 0 (12,862)
Unrealized (loss) gain on investments 56 0 0 0 56 0
Issuance of common stock under equity incentive and employee stock purchase plans 269 $ 0 269 0 0 0
Issuance of common stock under equity incentive and employee stock purchase plans, shares   43,395        
Employee stock-based compensation 2,856 $ 0 2,856 0 0 0
Compensation expense related to options granted to consultants 83 0 83 0 0 0
Ending Balance at Sep. 30, 2019 61,862 $ 58 475,869 (16) 409 (414,458)
Ending Balance, shares at Sep. 30, 2019   58,253,140        
Beginning Balance at Dec. 31, 2019 $ 66,000 $ 60 495,624 (16) 318 (429,986)
Beginning Balance, shares at Dec. 31, 2019 60,234,784 60,234,784        
Net loss $ (25,480) $ 0 0 0 0 (25,480)
Unrealized (loss) gain on investments (46) 0 0 0 (46) 0
Issuance of common stock upon follow-on offering, net of issuance costs 325,654 $ 6 325,648 0 0 0
Issuance of common stock upon follow-on offering, net of issuance costs, shares   5,980,000        
Issuance of common stock under equity incentive and employee stock purchase plans 26,498 $ 3 26,495 0 0 0
Issuance of common stock under equity incentive and employee stock purchase plans, shares   2,986,248        
Repurchased shares upon vesting of restricted stock units for tax withholdings (3,709) $ 0 (3,709) 0 0 0
Repurchased shares upon vesting of restricted stock units for tax withholdings, shares   (92,459)        
Employee stock-based compensation 15,171 $ 0 15,171 0 0 0
Compensation expense related to options granted to consultants 731 0 731 0 0 0
Ending Balance at Sep. 30, 2020 $ 404,819 $ 69 859,960 (16) 272 (455,466)
Ending Balance, shares at Sep. 30, 2020 69,108,573 69,108,573        
Beginning Balance at Jun. 30, 2020 $ 421,141 $ 69 852,006 (16) 488 (431,406)
Beginning Balance, shares at Jun. 30, 2020   68,803,400        
Net loss (24,060) $ 0 0 0 0 (24,060)
Unrealized (loss) gain on investments (216) 0 0 0 (216) 0
Issuance of common stock under equity incentive and employee stock purchase plans 2,005 $ 0 2,005 0 0 0
Issuance of common stock under equity incentive and employee stock purchase plans, shares   305,173        
Employee stock-based compensation 5,721 $ 0 5,721 0 0 0
Compensation expense related to options granted to consultants 228 0 228 0 0 0
Ending Balance at Sep. 30, 2020 $ 404,819 $ 69 $ 859,960 $ (16) $ 272 $ (455,466)
Ending Balance, shares at Sep. 30, 2020 69,108,573 69,108,573